High-dose carboplatin with etoposide in patients with recurrent thymoma: The Indiana University experience

Bone Marrow Transplantation

Volumn 28, Issue 5, 2001, Pages 435-438

  Hanna, N ^a   Gharpure, V S ^b   Abonour, R ^a   Cornetta, K ^a   Loehrer Sr , P J ^a,c  

^a INDIANA UNIVERSITY   (United States)

^b Abington Hem/Onc Associates   (United States)

^c WALTHER CANCER INSTITUTE   (United States)

Author keywords

Autologous stem cell transplantation; Relapse disease; Thymoma

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; OCTREOTIDE; PREDNISONE; VINBLASTINE;

ADULT; ARTICLE; BLOOD TOXICITY; BOLUS INJECTION; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG MEGADOSE; DRUG SENSITIVITY; DRUG TOLERABILITY; EXPERIENCE; FEASIBILITY STUDY; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG METASTASIS; LUNG PARENCHYMA; LUNG SURGERY; MOBILIZATION; PERIPHERAL BLOOD STEM CELL; PLEURA; PRIORITY JOURNAL; RECURRENT DISEASE; REFRACTORY PERIOD; RELAPSE; SALVAGE THERAPY; STANDARD; SURVIVAL; THYMOMA; THYMUS CANCER; UNITED STATES; UNIVERSITY;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; THYMOMA; THYMUS NEOPLASMS; TREATMENT OUTCOME;

EID: 0035165158     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703181     Document Type: Article

References (22)

1. Thymomas: Current experience and future directions in therapy
2. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited stage, unresectable thymoma: An Intergroup Trial
3. High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer
4. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
5. Optimal two-stage designs for phase II clinical trials
6. Confidence limits for probability of response in multi-stage phase II clinical trials
7. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: Final results of an Intergroup Trial
8. Chemotherapy for invasive thymoma: A 13 year experience
9. Effective interleukin-2 in invasive lymphoepithelial thymoma
10. A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed/refractory thymoma
11. Thymoma: A comparative study of clinical features, histologic features and survival in 200 cases
12. Aggressive treatment of intrathoracic recurrences of thymoma
13. Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide
14. EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma
15. Effect of adrenocorticosteroid therapy of myasthenia gravis on associated malignant thymomas
16. Chemotherapy of malignant thymoma
17. Dramatic response of recurrent invasive thymoma to high-dose corticosteroid
18. Successful treatment of a patient with a thymoma and pure red cell aplasia with octreotide and prednisone
19. Phase II study of somatostatin analogs and prednisone in chemotherapy-refractory thymoma patients
20. Salvage chemotherapy for recurrent invasive thymoma
21. Invasive thymoma successfully treated with high-dose chemotherapy followed by peripheral blood stem cell transplantation (PBSCT)
22. Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: Toxicity and antitumor activity in 26 patients with poor-risk malignancies